<Suppliers Price>

alpiropride

Names

[ CAS No. ]:
81982-32-3

[ Name ]:
alpiropride

[Synonym ]:
RIV 2093
5-(Methylaminosulfonyl)-N-[(1-allyl-2-pyrrolidinyl)methyl]-2-methoxy-4-aminobenzamide

Chemical & Physical Properties

[ Density]:
1.227g/cm3

[ Molecular Formula ]:
C17H26N4O4S

[ Molecular Weight ]:
382.47800

[ Exact Mass ]:
382.16700

[ PSA ]:
122.14000

[ LogP ]:
2.94740

[ Index of Refraction ]:
1.56

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CV2311580
CHEMICAL NAME :
Benzamide, 4-amino-2-methoxy-5-((methylamino)sulfonyl)-N-((1-(2- propenyl)-2-pyrrolidi nyl) methyl)-
CAS REGISTRY NUMBER :
81982-32-3
LAST UPDATED :
199009
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C17-H26-N4-O4-S
MOLECULAR WEIGHT :
382.53

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
3600 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4550179
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
184 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4550179
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
204 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4550179
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
44 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4550179

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.